This thesis is organized around two overlapping questions: (1) whether and how the current approach to the regulation of new medicines should be modified to manage issues generated by new biomedical products, and (2) whether this issue may be reduced to an epistemological and methodological analyses. I explore and discuss some philosophical issues related to these questions.
CLINICAL TRIALS AND DRUG REGULATION: A PHILOSOPHICAL INQUIRY / M. Andreoletti ; supervisor: M. Rescigno; added supervisor: D. Teira. DIPARTIMENTO DI SCIENZE DELLA SALUTE, Università degli Studi di Milano, 2018 Mar 26. 29. ciclo, Anno Accademico 2017. [10.13130/andreoletti-mattia_phd2018-03-26].
CLINICAL TRIALS AND DRUG REGULATION: A PHILOSOPHICAL INQUIRY
M. Andreoletti
2018
Abstract
This thesis is organized around two overlapping questions: (1) whether and how the current approach to the regulation of new medicines should be modified to manage issues generated by new biomedical products, and (2) whether this issue may be reduced to an epistemological and methodological analyses. I explore and discuss some philosophical issues related to these questions.
| File | Dimensione | Formato | |
|---|---|---|---|
|
phd_unimi_R10742.pdf
accesso aperto
Descrizione: tesi
Tipologia:
Tesi di dottorato completa
Dimensione
741.61 kB
Formato
Adobe PDF
|
741.61 kB | Adobe PDF | Visualizza/Apri |
Pubblicazioni consigliate
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
